.jpg?width=1000)
M&A Outlook: European Healthcare
A closer look at an industry widely considered 'pandemic proof'
Despite the impact of COVID across sectors and the global market, transactions in healthcare – notably pharma, biotech and medtech – have continued to flourish, demonstrating the increasing importance of healthcare in such a climate.
What's inside:
_add.png?height=45){kind=icon}
Take a closer look at the current and future state of Healthcare M&A in Europe and the companies and firms at the forefront of this activity.
✅ Europe’s specialist VC firms have continued to successfully raise funds
✅ High demand puts power in hands of Pharma and Biotech companies
✅ Medtech is on the rise amid a growing focus on digital health solutions
✅ Why M&A will be critical for accessing external innovation
✅ How Ansarada's advanced Virtual Data Room supports large healthcare transactions